Evidence map›Paper›PMID 24710613›Full record

Trial reportThe American journal of tropical medicine and hygiene2014

Sustained clearance of Mansonella ozzardi infection after treatment with ivermectin in the Brazilian Amazon.

Sergio de Almeida Basano, Gilberto Fontes, Jansen Fernandes Medeiros, Juliana Souza de Almeida Aranha Camargo, Luana Janaína Souza Vera, Marcos Paulo Parente Araújo, Maira Santiago Pires Parente, Ricardo de Godoi Mattos Ferreira, Pedro di Tárique Barreto Crispim, Luís Marcelo Aranha Camargo

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Phase III Clinical Trial to Evaluate Ivermectin in the Reduction ofThe American journal of tropical medicine and hygiene · 2018
    Trial
  2. Article
  3. Broadening the range of use cases for ivermectin - a review of the evidence.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2022
    Review
  4. An Overview of the Management of Mansonellosis.Research and reports in tropical medicine · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Mansonellosis: current perspectives.Research and reports in tropical medicine · 2018
    Review
  9. International journal of ophthalmology · 2017
    Article
  10. Review
  11. Article
  12. Mansonelliasis, a neglected parasitic disease in Haiti.Memorias do Instituto Oswaldo Cruz · 2014
    Review
  13. Detection ofTherapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sergio de Almeida BasanoSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Gilberto FontesSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Jansen Fernandes MedeirosSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Juliana Souza de Almeida Aranha CamargoSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Luana Janaína Souza VeraSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Marcos Paulo Parente AraújoSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Maira Santiago Pires ParenteSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Ricardo de Godoi Mattos FerreiraSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Pedro di Tárique Barreto CrispimSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil.
Luís Marcelo Aranha CamargoSecretaria de Saúde do Estado de Rondônia (Hospital Cemetron), Porto Velho, Rondônia, Brazil; Faculdade São Lucas, Porto Velho, Rondônia, Brasil; Universidade Federal de São João Del Rei, Campus Divinópolis, Minas Gerais, Brazil; Fundação Oswaldo Cruz, Fiocruz-Rondônia, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, Porto Velho, Rondônia, Brazil; Departamento de Parasitologia, Instituto de Ciências Biomédicas 5, Universidade de São Paulo, São Paulo, Brazil spider@icbusp.org.
Federal University of São João del-Rei · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapy for mansonelliasis is challenging because there is no standard drug recommended for its treatment. This non-randomized study was conducted to evaluate the effectiveness of a single dose of 0.15 mg/kg of ivermectin to reduce Mansonella ozzardi microfilaraemia in infected persons. A total of 74 patients were studied within the municipality of Lábrea, which is located in Amazonas State, Brazil. The patients were treated with ivermectin after detection of the parasite by blood examination. Significant microfilaraemia reduction was observed and its residual effect was maintained for at least 12 months. There was no significant change in the laboratory blood count, hepatic metabolites, and nitrogen-bounding compound excreta dosage values that could compromise the use of this drug, demonstrating that ivermectin has a low toxicity level.

Indexed as

AdolescentAdultAnimalsAntiparasitic AgentsBrazilChildChild, PreschoolFemaleHematologic TestsHumansIvermectinMaleMansonellaMansonelliasisMicrofilariaeMiddle AgedAntiparasitic AgentsIvermectin

Identifiers

PMID24710613
PMCPMC4047749
OpenAlexW2064096578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.